Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) EBIT (2020 - 2025)

Historic EBIT for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $7.7 million.

  • Alignment Healthcare's EBIT rose 13934.54% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 10206.0%. This contributed to the annual value of -$101.6 million for FY2024, which is 2054.66% up from last year.
  • According to the latest figures from Q3 2025, Alignment Healthcare's EBIT is $7.7 million, which was up 13934.54% from $22.7 million recorded in Q2 2025.
  • In the past 5 years, Alignment Healthcare's EBIT registered a high of $22.7 million during Q2 2025, and its lowest value of -$52.7 million during Q1 2021.
  • Over the past 5 years, Alignment Healthcare's median EBIT value was -$32.5 million (recorded in 2023), while the average stood at -$26.9 million.
  • In the last 5 years, Alignment Healthcare's EBIT tumbled by 92959.92% in 2021 and then soared by 22375.15% in 2025.
  • Alignment Healthcare's EBIT (Quarter) stood at -$43.5 million in 2021, then decreased by 19.88% to -$52.1 million in 2022, then grew by 19.56% to -$41.9 million in 2023, then skyrocketed by 46.21% to -$22.5 million in 2024, then skyrocketed by 134.07% to $7.7 million in 2025.
  • Its EBIT was $7.7 million in Q3 2025, compared to $22.7 million in Q2 2025 and -$5.4 million in Q1 2025.